MeitY TIDE 2.0 Entrepreneur-in-Residence (EiR) at IIITB-IC
The MeitY TIDE 2.0 Entrepreneur-in-Residence (EiR) grant, implemented through the IIITB Innovation Centre, is designed to support individuals and startups at the prototype stage. It provides funding of up to Rs. 4 lakhs for a period of 12 months to validate and develop an idea into a Proof-of-Concept. The program focuses on socially-relevant solutions and ventures that utilize emerging digital technologies like SaaS/PaaS/IoT, AI, Blockchain, and Robotics.
About this scheme
The MeitY TIDE 2.0 Entrepreneur-in-Residence (EiR) grant, implemented through the IIITB Innovation Centre, is designed to support individuals and startups at the prototype stage. It provides funding of up to Rs. 4 lakhs for a period of 12 months to validate and develop an idea into a Proof-of-Concept. The program focuses on socially-relevant solutions and ventures that utilize emerging digital technologies like SaaS/PaaS/IoT, AI, Blockchain, and Robotics.
Who can apply
- Indian entrepreneurs with a well-defined business idea in sectors aligned to IIITB-Innovation Centre's focus areas.
- The grant is intended for startups at the prototype stage.
- The venture should be working on socially-relevant solutions using emerging digital technologies.
- Focus areas include: Healthcare, Education, Agriculture, Infrastructure & Transportation, Financial Inclusion including Digital Payments, and e-Governance, Smart Manufacturing & Industry 4.0/5.0, and FinTech.
Ready to apply? Get the official link
Applications are submitted directly with IIITB Innovation Centre, in your own name. Share a few details and we will point you to the official application portal and help you prepare a complete submission.
Here is the official application link
Apply in your own name with IIITB Innovation Centre. Want a second pair of eyes before you submit? An IncorpX advisor can help you prepare.
Open the official applicationFrequently asked questions
How much funding does MeitY TIDE 2.0 Entrepreneur-in-Residence (EiR) at IIITB-IC provide?
MeitY TIDE 2.0 Entrepreneur-in-Residence (EiR) at IIITB-IC provides up to Rs. 4 lakh. The exact amount sanctioned depends on the proposal and the evaluation by the program authority.
Is MeitY TIDE 2.0 Entrepreneur-in-Residence (EiR) at IIITB-IC currently accepting applications?
Closed on Aug 17, 2025. Always confirm the current window with the program authority before preparing your application.
Does MeitY TIDE 2.0 Entrepreneur-in-Residence (EiR) at IIITB-IC take equity?
No. This program is listed as equity-free, which means the funding does not dilute your shareholding. Review the official terms for any debt or convertible components.
IncorpX is a private platform operated by a private company. It is not a government department, agency or official portal, and it is not affiliated with, endorsed by, or acting on behalf of any government body or of any organisation, incubator, accelerator, investor or partner listed in this directory. All program names, logos and trademarks are the property of their respective owners and are used for identification only.
This directory is compiled from publicly available official sources and is provided for general information only. It does not constitute legal, financial, tax or professional advice. Funding amounts, eligibility criteria, required documents, deadlines and availability are determined by each program authority and change with every cycle, so the details shown here may be incomplete or out of date. Always confirm the current terms on the official program source before you apply or take any decision.
IncorpX charges no fee for the information in this directory and does not collect, process, lodge or submit any application on your behalf. Applications are made by you, in your own name, directly with the respective program authority. IncorpX provides assistance only for application preparation and for related registrations such as company incorporation, DPIIT recognition, MSME (Udyam) and GST. Eligibility, approval, disbursement and selection rest solely with the respective program authority, and IncorpX makes no representation or guarantee as to any outcome.
